Rapid Nutrition PLC (ALRPD.PA)
EUR 0.04
(0.92%)
EUR 0.04
(0.92%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 14.52 Thousand AUD | -93.99% |
| 2022 | 241.87 Thousand AUD | -66.32% |
| 2021 | 718.14 Thousand AUD | 70.62% |
| 2020 | 420.9 Thousand AUD | 0.0% |
| 2018 | 1.4 Million AUD | 104.02% |
| 2017 | 688.84 Thousand GBP | 153.6% |
| 2016 | 271.62 Thousand GBP | -15.59% |
| 2015 | 321.77 Thousand GBP | 516.19% |
| 2014 | 52.22 Thousand GBP | -25.79% |
| 2013 | 70.36 Thousand GBP | -7.28% |
| 2012 | 75.89 Thousand AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q4 | 14.52 Thousand AUD | 0.0% |
| 2023 FY | 14.52 Thousand AUD | -93.99% |
| 2023 Q2 | 109.02 Thousand AUD | 0.0% |
| 2023 Q1 | 109.02 Thousand AUD | -54.92% |
| 2023 Q3 | 14.52 Thousand AUD | -86.68% |
| 2022 FY | 241.87 Thousand AUD | -66.32% |
| 2022 Q4 | 241.87 Thousand AUD | 0.0% |
| 2022 Q3 | 241.87 Thousand AUD | 83.06% |
| 2022 Q2 | 132.12 Thousand AUD | 0.0% |
| 2022 Q1 | 132.12 Thousand AUD | -81.6% |
| 2021 Q1 | 638.78 Thousand AUD | 0.0% |
| 2021 Q3 | 718.14 Thousand AUD | 12.42% |
| 2021 Q4 | 718.14 Thousand AUD | 0.0% |
| 2021 Q2 | 638.78 Thousand AUD | 0.0% |
| 2021 FY | 718.14 Thousand AUD | 70.62% |
| 2020 FY | 420.9 Thousand AUD | 0.0% |
| 2019 Q1 | 770.92 Thousand AUD | 513.89% |
| 2019 Q4 | 1.83 Million AUD | 0.0% |
| 2019 Q3 | 1.83 Million AUD | 30.34% |
| 2019 Q2 | 1.4 Million AUD | 82.29% |
| 2018 FY | 1.4 Million AUD | 104.02% |
| 2018 Q4 | 125.58 Thousand GBP | 0.0% |
| 2018 Q3 | 125.58 Thousand AUD | -81.77% |
| 2018 Q1 | 706.88 Thousand AUD | 68.77% |
| 2018 Q2 | 688.84 Thousand GBP | -2.55% |
| 2017 FY | 688.84 Thousand GBP | 153.6% |
| 2017 Q3 | 412.98 Thousand AUD | 52.04% |
| 2017 Q1 | 263.11 Thousand AUD | -35.94% |
| 2017 Q2 | 271.62 Thousand GBP | 3.23% |
| 2017 Q4 | 418.83 Thousand GBP | 1.42% |
| 2016 Q4 | 410.74 Thousand GBP | 38.85% |
| 2016 Q2 | 321.77 Thousand GBP | 33.91% |
| 2016 Q1 | 240.29 Thousand AUD | 221.02% |
| 2016 FY | 271.62 Thousand GBP | -15.59% |
| 2016 Q3 | 295.81 Thousand AUD | -8.07% |
| 2015 Q4 | 74.85 Thousand GBP | 0.0% |
| 2015 Q3 | 74.85 Thousand AUD | 43.35% |
| 2015 Q2 | 52.22 Thousand GBP | 0.0% |
| 2015 Q1 | 52.22 Thousand AUD | -23.7% |
| 2015 FY | 321.77 Thousand GBP | 516.19% |
| 2014 Q3 | 68.44 Thousand AUD | -2.73% |
| 2014 Q2 | 70.36 Thousand AUD | 0.0% |
| 2014 Q4 | 68.44 Thousand GBP | 0.0% |
| 2014 FY | 52.22 Thousand GBP | -25.79% |
| 2013 Q2 | 75.89 Thousand AUD | 0.0% |
| 2013 FY | 70.36 Thousand GBP | -7.28% |
| 2012 FY | 75.89 Thousand AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AB Science S.A. | 16.98 Million EUR | 99.914% |
| Boiron SA | 6.64 Million EUR | 99.781% |
| Fagron NV | 325.03 Million EUR | 99.996% |
| Ipsen S.A. | 341.4 Million EUR | 99.996% |
| Malin Corporation plc | - EUR | -Infinity% |
| Vetoquinol SA | 9.66 Million EUR | 99.85% |